Gene · 1948
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors. | Transl Oncol | 2023 | 37354638 | PubTator, text mining | PubMed |
| Scutellarin inhibits the glioma cell proliferation by downregulating BIRC5 to promote cell apoptosis. | J Cell Mol Med | 2023 | 37340587 | PubTator, text mining | PubMed |
| Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells. | J Cell Biol | 2023 | 37338522 | PubTator, text mining | PubMed |
| Genetically engineering endothelial niche in human kidney organoids enables multilineage maturation, vascularization and de novo cell types. | bioRxiv | 2023 | 37333155 | PubTator, text mining | PubMed |
| Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer. | J Cancer | 2023 | 37325052 | PubTator, text mining | PubMed |
| Genetic and epigenetic background of diabetic kidney disease. | Front Endocrinol (Lausanne) | 2023 | 37324271 | PubTator, text mining | PubMed |
| Non-typical persistent hyperplastic primary vitreous: a rare case report and review of the literature. | BMC Ophthalmol | 2023 | 37312173 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals tumor antigen and immune subtypes of melanoma. | Oncol Res | 2023 | 37305390 | PubTator, text mining | PubMed |
| Precision Medicine to Treat Urothelial Carcinoma-The Way Forward. | Cancers (Basel) | 2023 | 37296985 | PubTator, text mining | PubMed |
| Stromal-Epithelial Interactions in Cancer Progression and Therapy Response. | Cancers (Basel) | 2023 | 37296976 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal changes in cell heterogeneity during progression of human tendinopathy. | BMC Biol | 2023 | 37280595 | PubTator, text mining | PubMed |
| Prevascularization techniques for dental pulp regeneration: potential cell sources, intercellular communication and construction strategies. | Front Bioeng Biotechnol | 2023 | 37274160 | PubTator, text mining | PubMed |
| Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. | Front Neurol | 2023 | 37273690 | PubTator, text mining | PubMed |
| Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. | Acta Pharm Sin B | 2023 | 37250154 | PubTator, text mining | PubMed |
| PhosY-secretome profiling combined with kinase-substrate interaction screening defines active c-Src-driven extracellular signaling. | Cell Rep | 2023 | 37243593 | PubTator, text mining | PubMed |
| A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses. | Viruses | 2023 | 37243163 | PubTator, text mining | PubMed |
| EphrinB2 drives osteogenic fate of adult cardiac fibroblasts in a calcium influx dependent manner. | Am J Physiol Cell Physiol | 2023 | 37212547 | PubTator, text mining | PubMed |
| Meta-analysis of expression and the targeting of cell adhesion associated genes in nine cancer types - A one research lab re-evaluation. | Comput Struct Biotechnol J | 2023 | 37206618 | PubTator, text mining | PubMed |
| Connexin 37 sequestering of activated-ERK in the cytoplasm promotes p27-mediated endothelial cell cycle arrest. | Life Sci Alliance | 2023 | 37197981 | PubTator, text mining | PubMed |
| IKKβ Inhibition Attenuates Epithelial Mesenchymal Transition of Human Stem Cell-Derived Retinal Pigment Epithelium. | Cells | 2023 | 37190063 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1948/papers?page=16